Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation

The invention relates to the use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation for the treatment of androgen-induced disorders and for hormone replacement therapy and for the treatment of dysmenorrhoea and for stabilising the menstrual cycle...

Full description

Saved in:
Bibliographic Details
Main Authors SCHRAMM GEORG, WILSMANN KLAUS-MICHAEL, KLOSE JANINE, BARTHOLOMAUS JOHANNES
Format Patent
LanguageEnglish
Published 01.12.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation for the treatment of androgen-induced disorders and for hormone replacement therapy and for the treatment of dysmenorrhoea and for stabilising the menstrual cycle and for the treatment of menstrual cycle-dependent complaints and for contraception simultaneously in women.
Bibliography:Application Number: US20040009361